BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Credit Suisse maintains outperform on Dr. Reddy's Laboratories
The brokerage expects Dr. Reddys Laboratories's (DRL) earnings to get a boost on the back of strong market share gain. DRL is currently trading at 15 per cent discount to Sun Pharmaceuticals and Lupin, added Credit Suisse.